摘要
Percutaneous nephrolithotomy （PCNL） has been the first-line treatment for renal staghorn calculi for many years. Several techniques have been described for percutaneous access and stone removal, but a multi-access approach is the mainstay of treatment. The main concern about PCNL is the resultant morbidity： Complications such as bleeding, parenchymal damage, and organ injury hindered the adoption of PCNL in primary hospitals in China.
Percutaneous nephrolithotomy （PCNL） has been the first-line treatment for renal staghorn calculi for many years. Several techniques have been described for percutaneous access and stone removal, but a multi-access approach is the mainstay of treatment. The main concern about PCNL is the resultant morbidity： Complications such as bleeding, parenchymal damage, and organ injury hindered the adoption of PCNL in primary hospitals in China.
